Eli Lilly and Co said on Friday the U.S. health regulator approved its drug for the treatment of a rare form of blood cancer.
The wholesale cost of the treatment, Jaypirca, will be $21,000 per 30 days for the 200 mg dose, the U.S. drugmaker told Reuters.
The Food and Drug Administration's accelerated approval for Jaypirca marks the first of the five treatments the U.S. drugmaker hopesThe drug, which is expected to be available in the United States in the coming weeks, aims to treat adults with mantle cell lymphoma after at least two lines of therapy.
Mantle cell lymphoma is a rare type of blood cancer that starts in white blood cells in the lymph nodes and aggressively spreads to other parts of the body. Jaypirca's approval is based on data from a subset of 120 patients in an early-to-mid stage trial that showed half of them responded to the drug, while 13% achieved a complete response.
The trial assessed the efficacy of 200 mg dose of the drug until disease progression or unacceptable toxicity.had rejected an accelerated approval of Lilly's experimental Alzheimer's drug donanemab because the company had not submitted enough trial data from patients who were treated for at least a year.Our Standards:
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Indianapolis nonprofit partnering with Eli Lilly for new program, opportunitiesThe partnership will allow cohort members to complete Microsoft and Google certifications in a completely remote environment. You don't need an undergraduate degree or a ton of prerequisites to join.
Consulte Mais informação »
Senior FDA official resigns in wake of 2022 infant formula shortage, acknowledges FDA communication breakdownsFDA's Deputy Commissioner for Food Policy and Response, Frank Yiannas, has announced he is resigning from his post. His departure comes in the wake of last year's infant formula shortage, throughout which Yiannas held a prominent leadership role.
Consulte Mais informação »
FDA proposes allowing gay and bisexual monogamous men to donate bloodFDA announces it will ease blood donation restrictions on gay and bisexual men, including allowing those in monogamous relationships to donate.
Consulte Mais informação »
Arizona's new Reps. Juan Ciscomani and Eli Crane to sit on these House committeesRepublicans Juan Ciscomani and Eli Crane, Arizona's freshmen members of Congress, got some plumb committee assignments.
Consulte Mais informação »
Keeping up with the Manning brothers: How retirement is keeping both Eli and Peyton busyAfter their retirements from the NFL, America has welcomed the Manning brothers back into their homes on Monday night as the two co-hosts of ESPN's 'ManningCast.'
Consulte Mais informação »
FDA Will Now Allow Blood Donations From Gay, Bisexual Men and Transgender WomenThe FDA has announced that it will be ending blood donation restrictions that have discriminated against gay and bisexual men since 1985.
Consulte Mais informação »